The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. President Trump and HHS Secretary Kennedy emphasize transparency and ...

This week, the agency announced it sent out thousands of letters to pharmaceutical companies warning them to remove misleading ads. About 100 cease-and-desist letters were also sent to companies that ...

The US Food and Drug Administration on Tuesday released approximately 100 warning letters it had sent to drug companies on September 9, alleging that the companies made false or misleading claims on ...

Companies’ false advertisements and other deceptive business practices can have significant adverse commercial consequences for their competitors. Along with short-term loss of business, misleading ...

Companies can sue for false advertising in various circumstances. If your company is facing revenue losses due to a competitor’s false or misleading statements or omissions in its advertisements, it ...